BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 28739033)

  • 1. Soluble ST2 for Risk Stratification and the Prediction of Mortality in Patients Undergoing Transcatheter Aortic Valve Implantation.
    Stundl A; Lünstedt NS; Courtz F; Freitag-Wolf S; Frey N; Holdenrieder S; Zur B; Grube E; Nickenig G; Werner N; Frank D; Sinning JM
    Am J Cardiol; 2017 Sep; 120(6):986-993. PubMed ID: 28739033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ST2 predicts survival in patients undergoing transcatheter aortic valve implantation.
    Schmid J; Stojakovic T; Zweiker D; Scharnagl H; Maderthaner RD; Scherr D; Maier R; Schmidt A; März W; Binder JS; Rainer PP
    Int J Cardiol; 2017 Oct; 244():87-92. PubMed ID: 28651919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble ST2 predicts 1-year outcome in patients undergoing transcatheter aortic valve implantation.
    Wernly B; Lichtenauer M; Jirak P; Eder S; Reiter C; Kammler J; Kypta A; Jung C; Franz M; Hoppe UC; Landmesser U; Figulla HR; Lauten A
    Eur J Clin Invest; 2017 Feb; 47(2):149-157. PubMed ID: 28036122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated growth differentiation factor 15 levels predict outcome in patients undergoing transcatheter aortic valve implantation.
    Krau NC; Lünstedt NS; Freitag-Wolf S; Brehm D; Petzina R; Lutter G; Bramlage P; Dempfle A; Frey N; Frank D
    Eur J Heart Fail; 2015 Sep; 17(9):945-55. PubMed ID: 26230285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-B-type natriuretic peptide-ratio predicts mortality after transcatheter aortic valve replacement.
    Stähli BE; Gebhard C; Saleh L; Falk V; Landmesser U; Nietlispach F; Maisano F; Lüscher TF; Maier W; Binder RK
    Catheter Cardiovasc Interv; 2015 Jun; 85(7):1240-7. PubMed ID: 25511571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolution and prognostic value of N-terminal brain natriuretic peptide in predicting 1-year mortality in patients following transcatheter aortic valve implantation.
    Elhmidi Y; Bleiziffer S; Piazza N; Ruge H; Krane M; Deutsch MA; Hettich I; Voss B; Mazzitelli D; Lange R
    J Invasive Cardiol; 2013 Jan; 25(1):38-44. PubMed ID: 23293174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of N-terminal pro-B-type natriuretic peptide response on long-term prognosis after transcatheter aortic valve implantation for severe aortic stenosis and heart failure.
    Kaneko H; Hoelschermann F; Tambor G; Okamoto M; Neuss M; Butter C
    Heart Vessels; 2019 May; 34(5):777-783. PubMed ID: 30443765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients.
    Obokata M; Sunaga H; Ishida H; Ito K; Ogawa T; Ando Y; Kurabayashi M; Negishi K
    Am Heart J; 2016 Sep; 179():29-41. PubMed ID: 27595677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periprocedural Changes of NT-proBNP Are Associated With Survival After Transcatheter Aortic Valve Implantation.
    Seoudy H; Frank J; Neu M; Güßefeld N; Klaus Y; Freitag-Wolf S; Lambers M; Lutter G; Dempfle A; Rangrez AY; Kuhn C; Frey N; Frank D
    J Am Heart Assoc; 2019 Feb; 8(3):e010876. PubMed ID: 30686097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of N-terminal pro-B-type natriuretic peptide in patients with normal left ventricular ejection fraction undergoing transcatheter aortic valve implantation.
    Seoudy H; Kuhn C; Frank J; Eden M; Rangrez AY; Lutter G; Frey N; Frank D
    Int J Cardiol; 2020 Feb; 301():195-199. PubMed ID: 31757644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk scores and biomarkers for the prediction of 1-year outcome after transcatheter aortic valve replacement.
    Sinning JM; Wollert KC; Sedaghat A; Widera C; Radermacher MC; Descoups C; Hammerstingl C; Weber M; Stundl A; Ghanem A; Widder J; Vasa-Nicotera M; Mellert F; Schiller W; Bauersachs J; Zur B; Holdenrieder S; Welz A; Grube E; Pencina MJ; Nickenig G; Werner N; Kempf T
    Am Heart J; 2015 Oct; 170(4):821-9. PubMed ID: 26386807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-procedural N-terminal pro-brain natriuretic peptide predicts one-year mortality after transcatheter aortic valve implantation.
    Vale NC; Campante Teles R; Madeira S; Brito J; Sousa Almeida M; Nolasco T; Abecasis J; Rodrigues G; Carmo J; Furstenau M; Ribeiras R; Neves JP; Mendes M
    Rev Port Cardiol (Engl Ed); 2018 Jan; 37(1):67-73. PubMed ID: 29317115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic utility of novel biomarkers of cardiovascular stress in patients with aortic stenosis undergoing valve replacement.
    Lindman BR; Breyley JG; Schilling JD; Vatterott AM; Zajarias A; Maniar HS; Damiano RJ; Moon MR; Lawton JS; Gage BF; Sintek MA; Aquino A; Holley CL; Patel NM; Lawler C; Lasala JM; Novak E
    Heart; 2015 Sep; 101(17):1382-8. PubMed ID: 26037104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ST2 elevation in heart failure, predictive of a high early mortality.
    Dalal JJ; Digrajkar A; Das B; Bansal M; Toomu A; Maisel AS
    Indian Heart J; 2018; 70(6):822-827. PubMed ID: 30580851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post procedural risk assessment in patients undergoing trans aortic valve implantation according to the age, creatinine, and ejection fraction-7 score: Advantages of age, creatinine, and ejection fraction-7 in stratification of post-procedural outcome.
    Denegri A; Mehran R; Holy E; Taramasso M; Pasotti E; Pedrazzini G; Moccetti T; Maisano F; Nietlispach F; Obeid S
    Catheter Cardiovasc Interv; 2019 Jan; 93(1):141-148. PubMed ID: 30269398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EuroSCORE II and STS as mortality predictors in patients undergoing TAVI.
    Rosa VE; Lopes AS; Accorsi TA; Fernandes JR; Spina GS; Sampaio RO; Paixão MR; Pomerantzeff PM; Lemos Neto PA; Tarasoutchi F
    Rev Assoc Med Bras (1992); 2016; 62(1):32-7. PubMed ID: 27008490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical Risk Scores Applied to Transcatheter Aortic Valve Implantation: Friends or Foes? Short-Term and Long-Term Outcomes From a Single-Center Registry.
    Compagnone M; Moretti C; Marcelli C; Taglieri N; Ghetti G; Corsini A; Bruno M; Bruno AG; Orzalkiewicz M; Marrozzini C; Bacchi Reggiani ML; Palmerini T; Saia F
    J Invasive Cardiol; 2019 Oct; 31(10):E282-E288. PubMed ID: 31567116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The integrated value of sST2 and global longitudinal strain in the early stratification of patients with severe aortic valve stenosis: a translational imaging approach.
    Fabiani I; Conte L; Pugliese NR; Calogero E; Barletta V; Di Stefano R; Santoni T; Scatena C; Bortolotti U; Naccarato AG; Petronio AS; Di Bello V
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1915-1920. PubMed ID: 28664478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-Analysis of Impact of Baseline N-TerminalPro-Brain Natriuretic Peptide Levels on SurvivalAfter Transcatheter Aortic Valve Implantation for Aortic Stenosis.
    Takagi H; Hari Y; Kawai N; Kuno T; Ando T;
    Am J Cardiol; 2019 Mar; 123(5):820-826. PubMed ID: 30587374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated high-sensitivity troponin T levels at 1-year follow-up are associated with increased long-term mortality after TAVR.
    Seoudy H; Lambers M; Winkler V; Dudlik L; Freitag-Wolf S; Frank J; Kuhn C; Rangrez AY; Puehler T; Lutter G; Bramlage P; Frey N; Frank D
    Clin Res Cardiol; 2021 Mar; 110(3):421-428. PubMed ID: 33098469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.